⇚ Regimen JAYPIRCA® - for Mantle Cell Lymphoma Medical Name JAYPIRCA® (Pirtobrutinib) for Mantle Cell Lymphoma Cycles Given N/A Delivery Phases 1 Special Instructions Given orally once daily with or without food. Monitor for infections, hemorrhage, cytopenias and Atrial Fibrillation/Flutter. Treatment given until disease progression or unacceptable toxicity References Wang ML, et al. J Clin Oncol 2023 - VIEW External References http://pubmed.ncbi.nlm.nih.gov/37192437/ - VIEW First Phase Drug Mode Given Standard Dose Days to Be Given Frequency Solution Volume Duration JAYPIRCA® (Pirtobrutinib) PO 200 mg D1 thru D28 q28 N/A N/A N/A